Uptake of dihomo-γ-linolenic acid by murine macrophages increases series-1 prostaglandin release following lipopolysaccharide treatment

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 83, Issue 1, 2010, Pages 23-29

  Kakutani, Saki ^a   Kawashima, Hiroshi ^a   Tanaka, Takao ^a   Shiraishi Tateishi, Akiko ^a   Kiso, Yoshinobu ^a  

^a Suntory Wellness Limited Research Center   (Japan)

Author keywords

Dihomo linolenic acid; LC MS MS; Mouse peritoneal macrophage; Prostaglandins

Indexed keywords

ARACHIDONIC ACID; DIHOMO GAMMA LINOLENIC ACID; ICOSAPENTAENOIC ACID; LIPOPOLYSACCHARIDE; POLYUNSATURATED FATTY ACID; PROSTAGLANDIN; PROSTAGLANDIN D1; PROSTAGLANDIN D2; PROSTAGLANDIN D3; PROSTAGLANDIN E1; PROSTAGLANDIN E2; PROSTAGLANDIN E3; PROSTAGLANDIN E3ALPHA; PROSTAGLANDIN F1 ALPHA; PROSTAGLANDIN F2 ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELL STIMULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; IN VIVO STUDY; LIQUID CHROMATOGRAPHY; MALE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE; TANDEM MASS SPECTROMETRY;

8,11,14-EICOSATRIENOIC ACID; ALPROSTADIL; ANIMALS; ARACHIDONIC ACID; DERMATITIS, ATOPIC; DOSE-RESPONSE RELATIONSHIP, DRUG; EICOSANOIC ACIDS; HUMANS; LIPOPOLYSACCHARIDES; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED BALB C; PROSTAGLANDINS D;

MURINAE; MUS;

EID: 77953538471     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plefa.2010.02.032     Document Type: Article

References (28)

1. James M.J., Gibson R.A., Cleland L.G. Dietary polyunsaturated fatty acids and inflammatory mediator production. Am. J. Clin. Nutr. 2000, 71:343S-348S.
2. Calder P.C. Polyunsaturated fatty acids, inflammation, and immunity. Lipids 2001, 36:1007-1024.
3. Benatti P., Peluso G., Nicolai R., Calvani M. Polyunsaturated fatty acids: biochemical, nutritional and epigenetic properties. J. Am. Coll. Nutr. 2004, 23:281-302.
4. Dyerberg J., Bang H.O., Stoffersen E., Moncada S., Vane J.R. Eicosapentaenoic acid and prevention of thrombosis and atherosclerosis?. Lancet 1978, 2:117-119.
5. Smith W.L., DeWitt D.L., Garavito R.M. Cyclooxygenases: structural, cellular, and molecular biology. Annu. Rev. Biochem. 2000, 69:145-182.
6. Funk C.D. Prostaglandins and leukotrienes: advances in eicosanoid biology. Science 2001, 294:1871-1875.
7. Helliwell R.J.A., Adams L.F., Mitchell M.D. Prostaglandin synthase: recent developments and a novel hypothesis. Prostaglandins Leukot. Essent. Fatty Acids 2004, 70:101-113.
8. Lewis R.A., Austen K.F., Soberman R.J. Leukotrienes and other products of the 5-lipoxygenase pathway. Biochemistry and relation to pathobiology in human diseases. N. Engl. J. Med. 1990, 323:645-655.
9. Bagga D., Wang L., Farias-Eisner R., Glaspy J.A., Reddy S.T. Differential effects of prostaglandin derived from omega-6 and omega-3 polyunsaturated fatty acids on COX-2 expression and IL-6 secretion. Proc. Natl. Acad. Sci. USA 2003, 100:1751-1756.
10. Sinzinger H., Fitscha P., O'Grady J., Rauscha F., Rogatti W., Vane J.R. Synergistic effect of prostaglandin E1 and isosorbide dinitrate in peripheral vascular disease. Lancet 1990, 335:627-628.
11. Whittle B.J., Moncada S., Vane J.R. Comparison of the effects of prostacyclin (PGI2), prostaglandin E1 and D2 on platelet aggregation in different species. Prostaglandins 1978, 16:373-388.
12. Kawashima H., Tateishi N., Shiraishi A., et al. Oral administration of dihomo-γ-linolenic acid prevents development of atopic dermatitis in NC/Nga mice. Lipids 2008, 43:37-43.
13. Takai S., Jin D., Kawashima H., et al. Anti-atherosclerotic effects of dihomo-γ-linolenic acid in apoE-deficient mice. J. Atheroscler. Thromb. 2009, 16:480-489.
14. Shono F., Yokota K., Horie K., et al. A heterologous enzyme immunoassay of prostaglandin E2 using a stable enzyme-labeled hapten mimic. Anal. Biochem. 1988, 168:284-291.
15. Hiroshima O., Hayashi H., Ito S., Hayaishi O. Basal level of prostaglandin D2 in rat brain by a solid-phase enzyme immunoassay. Prostaglandins 1986, 32:63-80.
16. Reinke M. Monitoring thromboxane in body fluids: a specific ELISA for 11-dehydrothromboxane B2 using a monoclonal antibody. Am. J. Physiol. 1992, 262:E658-E662.
17. Kempen E.C., Yang P., Felix E., Madden T., Newman R.A. Simultaneous quantification of arachidonic acid metabolites in cultured tumor cells using high-performance liquid chromatography/electrospray ionization tandem mass spectrometry. Anal. Biochem. 2001, 297:183-190.
18. Kita Y., Takahashi T., Uozumi N., Shimizu T. A multiplex quantitation method for eicosanoids and platelet-activating factor using column-switching reversed-phase liquid chromatography-tandem mass spectrometry. Anal. Biochem. 2005, 342:134-143.
19. Hishinuma T., Suzuki K., Saito M., et al. Simultaneous quantification of seven prostanoids using liquid chromatography/tandem mass spectrometry: the effects of arachidonic acid on prostanoid production in mouse bone marrow-derived mast cells. Prostaglandins Leukot. Essent. Fatty Acids 2007, 76:321-329.
20. Masoodi M., Nicolaou A. Lipidomic analysis of twenty-seven prostanoids and isoprostanes by liquid chromatography/electrospray tandem mass spectrometry. Rapid Commun. Mass Spectrom. 2006, 20:3023-3029.
21. Matsumoto H., Naraba H., Murakami M., et al. Concordant induction of prostaglandin E2 synthase with cyclooxygenase-2 leads to preferred production of prostaglandin E2 over thromboxane and prostaglandin D2 in lipopolysaccharide-stimulated rat peritoneal macrophages. Biochem. Biophys. Res. Commun. 1997, 230:110-114.
22. Lee S.H., Soyoola E., Chanmugam P., et al. Selective expression of mitogen-inducible cyclooxygenase in macrophages stimulated with lipopolysaccharide. J. Biol. Chem. 1992, 267:25934-25938.
23. Ueno N., Takegoshi Y., Kamei D., Kudo I., Murakami M. Coupling between cyclooxygenases and terminal prostanoid synthases. Biochem. Biophys. Res. Commun. 2005, 338:70-76.
24. Levin G., Duffin K.L., Obukowicz M.G., et al. Differential metabolism of dihomo-γ-linolenic acid and arachidonic acid by cyclo-oxygenase-1 and cyclo-oxygenase-2: implications for cellular synthesis of prostaglandin E1 and prostaglandin E2. Biochem. J. 2002, 365:489-496.
25. Wada M., DeLong C.J., Hong Y.H., et al. Enzymes and receptors of prostaglandin pathways with arachidonic acid-derived versus eicosapentaenoic acid-derived substrates and products. J. Biol. Chem. 2007, 282:22254-22266.
26. Yuan C., Sidhu R.S., Kuklev D.V., et al. Cyclooxygenase allosterism, fatty acid-mediated cross-talk between monomers of cyclooxygenase homodimers. J. Biol. Chem. 2009, 284:10046-10055.
27. Cipollone F., Fazia M., Iezzi A., et al. Balance between PGD synthase and PGE synthase is a major determinant of atherosclerotic plaque instability in humans. Arterioscler. Thromb. Vasc. Biol. 2004, 24:1259-1265.
28. Morse P.F., Horrobin D.F., Manku M.S., et al. Meta-analysis of placebo-controlled studies of the efficacy of Epogam in the treatment of atopic eczema. Relationship between plasma essential fatty acid changes and clinical response. Br. J. Dermatol. 1989, 121:75-90.